Weight Loss Lorcaseri Powder Raw Material Lorcaseri Powder Raw Powder Lorcaseri

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >99%
• Model NO.: D-sung-Lorcaseri
• Product Name: Lorcaseri
• Name: Lorcaseri Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC UV
• Shelf Life: 2 Years
• CAS No.: 616202-92-7
• Mf: C11h14cln
• MW: 195.68900
• Storage Conditions: Cool Dry Place
• Boiling Point: 288.125ºC at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 3000kg/Month

Product Description

Weight Loss Lorcaseri powder Raw material Lorcaseri powder Raw Powder Lorcaseri

Product Description

Product Details

 

 

Product Name	Lorcaseri
Appearance	white powder
Molecular formula	C11H14ClN
Molecular Weight	195.68900
Assay	99%

Lorcaseri is a new type of medication for the treatment of obesity, which is an orally effective selective 5-hydroxytryptamine 2C receptor agonist. Lorcaseri hydrochloride (BelviqTM) was successfully developed by Arena Company in the United States and was approved by the FDA on June 27, 2012. It is used as an adjuvant therapy for overweight Chemicalbook individuals who are obese or have at least one weight related complication on a low calorie diet and exercise basis. Clinical studies have shown that this drug can effectively reduce the weight of obese and overweight patients, improve obesity related metabolic indicators, and is well tolerated. The affinity of 5-HT2c for chlorhexidine is 100 times higher than that of 5-HT2B (risk of heart valve disease), and its safety is good. It was the first weight loss drug approved by the FDA after 1999. After one year of treatment with chlorhexidine, the average weight loss ranged from 3% to 3.7%.

Application&Function

Weight-reducing aid. Clokaselin can be used to treat opioid use disorders (OUD).

Specification